These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 1699911)

  • 1. Effect of FK-506 and cyclosporine on human T and B lymphoproliferative responses.
    Wasik M; Stepień-Sopniewska B; Lagodziński Z; Górski A
    Immunopharmacology; 1990; 20(1):57-61. PubMed ID: 1699911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of T and B lymphocyte proliferation by rapamycin.
    Kay JE; Kromwel L; Doe SE; Denyer M
    Immunology; 1991 Apr; 72(4):544-9. PubMed ID: 1709916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FK-506 and cyclosporin A inhibit highly similar signal transduction pathways in human T lymphocytes.
    Lin CS; Boltz RC; Siekierka JJ; Sigal NH
    Cell Immunol; 1991 Apr; 133(2):269-84. PubMed ID: 1707760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of the immunosuppressant FK-506 on alternate pathways of T cell activation.
    Bierer BE; Schreiber SL; Burakoff SJ
    Eur J Immunol; 1991 Feb; 21(2):439-45. PubMed ID: 1705513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunosuppressive macrolides FK-506 and rapamycin act as reciprocal antagonists in murine T cells.
    Dumont FJ; Melino MR; Staruch MJ; Koprak SL; Fischer PA; Sigal NH
    J Immunol; 1990 Feb; 144(4):1418-24. PubMed ID: 1689353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of T-lymphocyte activation by the immunosuppressive drug FK-506.
    Kay JE; Benzie CR; Goodier MR; Wick CJ; Doe SE
    Immunology; 1989 Aug; 67(4):473-7. PubMed ID: 2475433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of murine B-lymphocyte proliferation by the novel immunosuppressive drug FK-506.
    Walliser P; Benzie CR; Kay JE
    Immunology; 1989 Nov; 68(3):434-5. PubMed ID: 2480331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of FK-506 and low-concentration ciclosporin on human lymphocyte activation antigen expression and blastogenesis: a flow cytometric analysis.
    Woo J; Sewell HF; Thomson AW
    Scand J Immunol; 1990 Mar; 31(3):297-304. PubMed ID: 1690915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A.
    Zeevi A; Duquesnoy R; Eiras G; Rabinowich H; Todo S; Makowka L; Starzl TE
    Transplant Proc; 1987 Oct; 19(5 Suppl 6):40-4. PubMed ID: 2445073
    [No Abstract]   [Full Text] [Related]  

  • 10. Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin.
    Dumont FJ; Staruch MJ; Koprak SL; Melino MR; Sigal NH
    J Immunol; 1990 Jan; 144(1):251-8. PubMed ID: 1688572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of human T-cell activation by FK 506, rapamycin, and cyclosporine A.
    Sigal NH; Lin CS; Siekierka JJ
    Transplant Proc; 1991 Apr; 23(2 Suppl 2):1-5. PubMed ID: 1712132
    [No Abstract]   [Full Text] [Related]  

  • 12. Antigen presentation and HLA-DR expression by FK-506-treated human monocytes.
    Woo J; Propper DJ; Thomson AW
    Immunology; 1990 Dec; 71(4):551-5. PubMed ID: 1703987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of B cell activation by cyclosporin A, FK506 and rapamycin.
    Wicker LS; Boltz RC; Matt V; Nichols EA; Peterson LB; Sigal NH
    Eur J Immunol; 1990 Oct; 20(10):2277-83. PubMed ID: 1700753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T lymphocyte activation through the C28 pathway is insensitive to inhibition by the immunosuppressive drug FK-506.
    Kay JE; Benzie CR
    Immunol Lett; 1989 Dec; 23(2):155-9. PubMed ID: 2483716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of FK 506 and low concentration cyclosporine on human lymphocyte activation antigen expression: a flow cytometric analysis.
    Woo J; Sewell HF; Thomson AW
    Transplant Proc; 1990 Aug; 22(4):1645-6. PubMed ID: 1697113
    [No Abstract]   [Full Text] [Related]  

  • 16. Evidence that the immunosuppressive effects of FK506 and cyclosporine are identical.
    Johansson A; Möller E
    Transplantation; 1990 Dec; 50(6):1001-7. PubMed ID: 1701570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FK 506: an immunosuppressant for the 1990s?
    Macleod AM; Thomson AW
    Lancet; 1991 Jan; 337(8732):25-7. PubMed ID: 1702172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative immunoregulatory effects of rapamycin, FK 506 and cyclosporine on mitogen-induced cytokine production and lymphoproliferation.
    Wu J; Palladino MA; Figari IS; Morris RE
    Transplant Proc; 1991 Feb; 23(1 Pt 1):238-40. PubMed ID: 1703683
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of the effects of FK-506, cyclosporin A and rapamycin on IL-2 production.
    Henderson DJ; Naya I; Bundick RV; Smith GM; Schmidt JA
    Immunology; 1991 Jul; 73(3):316-21. PubMed ID: 1715317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The immunosuppressives FK 506 and cyclosporin A inhibit the generation of protein factors binding to the two purine boxes of the interleukin 2 enhancer.
    Brabletz T; Pietrowski I; Serfling E
    Nucleic Acids Res; 1991 Jan; 19(1):61-7. PubMed ID: 1707162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.